upadacitinib,adalimumab
abbvie
[' psa', '#0510', 'ada ', ' upa ']
mace and vte from 9 (6 ra, 2 psa, 1 as) rcts w/ upa. 6000+ pts received upa 40-50% w/ &gt; or = 2 bl cv risk factors. 41 mace upa 15mg ra-psa group &amp; 2 fatal vte upa 15mg ra group. overlapping confidence intervals w/ada &amp; mtx. abs#0510 #acr22 
MD, PhD Institute of Infection and Immunity @UofGlasgow UK. Past Co-chair of @EULAR Synovitis Study Group. CrossFit athlete and Mountains lover. Views my own.